1. Home
  2. MRSN vs ABLV Comparison

MRSN vs ABLV Comparison

Compare MRSN & ABLV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRSN
  • ABLV
  • Stock Information
  • Founded
  • MRSN 2001
  • ABLV 2015
  • Country
  • MRSN United States
  • ABLV China
  • Employees
  • MRSN N/A
  • ABLV N/A
  • Industry
  • MRSN Biotechnology: Pharmaceutical Preparations
  • ABLV
  • Sector
  • MRSN Health Care
  • ABLV
  • Exchange
  • MRSN Nasdaq
  • ABLV Nasdaq
  • Market Cap
  • MRSN 47.1M
  • ABLV 51.4M
  • IPO Year
  • MRSN 2017
  • ABLV N/A
  • Fundamental
  • Price
  • MRSN $9.76
  • ABLV $0.98
  • Analyst Decision
  • MRSN Strong Buy
  • ABLV
  • Analyst Count
  • MRSN 3
  • ABLV 0
  • Target Price
  • MRSN $33.00
  • ABLV N/A
  • AVG Volume (30 Days)
  • MRSN 69.2K
  • ABLV 21.0K
  • Earning Date
  • MRSN 11-12-2025
  • ABLV 04-23-2025
  • Dividend Yield
  • MRSN N/A
  • ABLV N/A
  • EPS Growth
  • MRSN N/A
  • ABLV N/A
  • EPS
  • MRSN N/A
  • ABLV 0.05
  • Revenue
  • MRSN $34,769,000.00
  • ABLV $114,319,869.00
  • Revenue This Year
  • MRSN N/A
  • ABLV N/A
  • Revenue Next Year
  • MRSN N/A
  • ABLV N/A
  • P/E Ratio
  • MRSN N/A
  • ABLV $19.66
  • Revenue Growth
  • MRSN 16.14
  • ABLV N/A
  • 52 Week Low
  • MRSN $5.21
  • ABLV $0.55
  • 52 Week High
  • MRSN $70.75
  • ABLV $1.77
  • Technical
  • Relative Strength Index (RSI)
  • MRSN 59.67
  • ABLV 51.82
  • Support Level
  • MRSN $8.76
  • ABLV $0.88
  • Resistance Level
  • MRSN $10.49
  • ABLV $1.12
  • Average True Range (ATR)
  • MRSN 0.84
  • ABLV 0.08
  • MACD
  • MRSN -0.06
  • ABLV -0.00
  • Stochastic Oscillator
  • MRSN 56.87
  • ABLV 39.88

About MRSN Mersana Therapeutics Inc.

Mersana Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing antibody-drug conjugates (ADCs) that offer a clinically meaningful benefit for cancer patients with unmet needs. The Company's next-generation ADC platforms include Dolasynthen, which delivers a proprietary auristatin payload, and Immunosynthen, which delivers a proprietary stimulator of interferon genes (STING) agonist payload. Its pipeline includes Emi-Le (XMT-1660), XMT-2056, XMT-2068, and XMT-2175.

About ABLV Able View Global Inc.

Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.

Share on Social Networks: